13F Data
13F filer · CIK 1053906

Artal Group S.A.

LUXEMBOURG, N4 · filing since Q2 2013 · last filing Aug 13, 2026
Reported value
$931.1M
$-79.5M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
1 / 1
Turnover
5.0%
buys $49.0M · sells $235.4M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedLexicon Pharmaceuticals Inc+20,421,735+13.2%+$49.0M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedCava Group Inc-3,000,000-31.6%$-235.4M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $3.2BQ3 2013: $3.1BQ4 2013: $2.8BQ1 2014: $2.8BQ2 2014: $2.5BQ3 2014: $2.7BQ4 2014: $2.8BQ1 2015: $2.2BQ2 2015: $2.3BQ3 2015: $4.5BQ4 2015: $5.3BQ1 2016: $5.1BQ2 2016: $4.8BQ3 2016: $5.1BQ4 2016: $4.5BQ1 2017: $4.5BQ2 2017: $5.7BQ3 2017: $5.8BQ4 2017: $6.6BQ1 2018: $8.0BQ2 2018: $4.7BQ3 2018: $3.8BQ4 2018: $2.7BQ1 2019: $2.4BQ2 2019: $2.5BQ3 2019: $2.5BQ4 2019: $2.6BQ1 2020: $2.4BQ2 2020: $3.6BQ3 2020: $4.1BQ4 2020: $4.7BQ1 2021: $5.7BQ2 2021: $4.9BQ3 2021: $4.5BQ4 2021: $3.7BQ1 2022: $2.4BQ2 2022: $1.9BQ3 2022: $2.3BQ4 2022: $1.8BQ1 2023: $1.7BQ2 2023: $3.2BQ3 2023: $2.3BQ4 2023: $3.0BQ1 2024: $3.9BQ2 2024: $3.9BQ3 2024: $2.4BQ4 2024: $1.2BQ1 2025: $884.2MQ2 2025: $930.2MQ3 2025: $758.2MQ4 2025: $714.6MQ1 2026: $1.0BQ2 2026: $931.1M
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1Cava Group IncCOM6,507,990$510.7M54.85%
2Lexicon Pharmaceuticals IncCOM NEW175,156,062$420.4M45.15%